Trial Profile
Comparison of intravitreal bevacizumab and dexamethasone implant for the treatment of macula oedema associated with branch retinal vein occlusion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Nov 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Dexamethasone
- Indications Branch retinal vein occlusion; Retinal oedema
- Focus Therapeutic Use
- 26 Nov 2015 New trial record